Laurent D. Hermouet, Partner Athyrium Capital Management

Laurent D. Hermouet

Partner


Laurent Hermouet is a Partner at Athyrium Capital Management LP and one of the firm’s three original members, playing a pivotal role in its founding in 2009. With over two decades of experience, Laurent has been integral in shaping Athyrium’s strategy and growth.

Laurent focuses on sourcing, diligencing, structuring, negotiating, and managing investments within the biotech, pharma, medtech, and pharma services sectors. His key investment strategies include direct/private lending, acquisition financing, and identifying special opportunities in both private and public markets. As a member of the Investment Committee, Laurent is deeply involved in the decision-making process and overall direction of the firm’s investment activities.

Representative investments under Laurent’s leadership include financings for Puma Biotechnology, Calliditas Therapeutics, Basilea Pharmaceutica, Portola Pharmaceuticals, Dermira, Kala Pharmaceuticals, OptiNose, Vivus, Aegerion Pharmaceuticals, Zealand Pharmaceuticals, Valneva SE, and Relypsa.

Prior to joining Athyrium, Laurent was a senior credit analyst at Tribeca Investments, a Citigroup-backed multi-strategy hedge fund, and a credit analyst at Goldman, Sachs & Co. Laurent holds a Master’s in Finance from the University of Paris-Dauphine and is a CFA® Charterholder.